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48, and 72 hours of the first dose of antibiotic administered. The urinary
bactericidal activity (UBA) was tested by determination of urinary bacteri-
cidal titers (UBT). Patient received cefepime for UTI were compared with
carbapenems to assess clinical therapeutic effectiveness.
Results: UBA were investigated for 4 ESBLs-producing E. coli uropathogens
and one control strain. In ex model, UBA of cefepime (median Log2UBTZ2;
range 0-4) for the tested was significantly higher than median UBTs of cefotax-
ime (median Log2UBTZ0; range 0-1; P<0.001) and cefuroxime (median
Log2UBTZ0; range 0-1: P<0.001). The calculated probability of target attain-
ment (PTA) rate for cefepime predicting therapeutic success approximated
92.5%. Of 17 patients received cefepime as definitive antimicrobial therapy
compare 9 patients received carbapenems for UTI caused by ESBLs-producing
E. coli. There were no significant differences in terms of breakthrough pyuria
(PZ0.52), recurrent UTI (PZ1.0), and mortality (PZ1.0) between two groups.
Conclusion: Cefepime if active in vitro demonstrated excellent urinary
bactericidal activity and appears to be a good alternative in the treatment
of UTI caused by ESBLs-producing E. coli.
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Purpose: The methicillin-resistant Staphylococcus aureus (MRSA) is arisen by
acquisition ofmecA, which is carried by the staphylococcal cassette chromo-
some (SCCmec). The oxacillin-susceptible S. aureus carrying SCCmec
(OSMRSA) implicates infection control of MRSA in even more complicated.
This study was purposed to estimate the prevalence and type OSMRSA among
nationwide collection of blood isolates in Korea since 2010.
Methods: The blood isolates of S. aureus were collected 27 university-affil-
iated hospitals across South Korea annually as up to 15 isolates per institute
and one per patient annually since 2011. All isolates were submitted to
MicroScan PBC28 panel (Siemens, West Sacramento, US) for species identifi-
cation and susceptibility test, and typed molecularly by SCCmec typing and
agr typing using multiplex PCR.
Results: Total of 323, 254, 216 and 184 isolates were collected in 2011, 2012,
2013, and 2014, respectively. Overall MRSA rates were 61.9%. Oxacillin MIC <
4 mg/mL but SCCmec-positive isolates were 4 (1.2%), 3 (1.1%), 7 (3.2%), and 3
(1.6%). 13 of those 17 were mecA-positive and the other 4 carried only rem-
nants of SCCmec; 6 SCCmecIVa-agr1, 4 SCCmecII- agr2, 1 SCCmecII-agr3, 1
SCCmecIa-agr1, and 2 dcs-positive of agr3 and nontypable agr, 1 kdp-positive
of agr1, and 1 rif4-positive of agr 1. Each 3 had oxacillin MIC of 1 or 2 mg/mL,
which comprised 3 SCCmecIVa-agr1 and 3 SCCmecII-agr2, and 5 of those
were corrected as MRSA by cefoxitin suceptibility. The other 11 had all
oxacillin MIC of <Z0.25 mg/mL. All but 3 SCCmecIVa-agr1 had resistance
to other class antimicrobials than b-lactams.
Conclusions: OSMRSA is 1.7% among blood isolates in Korea. Cefoxitin sus-
ceptibility and multidrug-resistant phenotypes would supplement oxacillin
susceptibility test to detect MRSA but not completely in routine laboratory
practice. MRSA surveillance for infection control may be better performed
using molecular tests targeted for mecA than phenotypic tests.
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Purpose: The emergence of carbapenem-resistant Enterobacteriaceae
(CRE) has severely limited the option of antimicrobial therapy against severe
infections caused by CRE. We aimed to evaluate the minimal inhibitory con-
centrations (MICs) of the potentially active antimicrobials against the CR-KP
isolates harboring the blaKPC-17 gene.Material and methods: We investigated the MICs of tigecycline, colistin, co-
trimoxazole, gentamicin and amikacin against 42 clinical isolates of imipe-
nem-resistant KP isolates recovered from patients hospitalized in a medical
center in southern Taiwan. MICs were determined by a standard dilution
method on Mueller-Hinton agar according to the Clinical Laboratory Standards
Institute. For KPC-2 full length sequencing, KPC-2-forward (5’- ATG TCA CTG
TAT CGC CGT CTA-3’) and KPC-2-reverse (5’-TTA CTG CCC GTT GAC GCC CA-
3’) were used. All amplicons were followed direct sequencing by ABI PRISM
3730. The sequences were further analyzed with the BLAST program.
Results: All the 42 isolates were confirmed to harbor the blaKPC-17 gene. For
amikacin, MICs distribution showed 40 isolates, < 4 mg/L; 1 isolate, 8 mg/L;
and 1 isolate > 32 mg/L. For gentamicin, MICs distribution showed 34 iso-
lates, < 1 mg/L and 8 isolates, > 8 mg/L. For co-trimoxazole, MIC distribu-
tion (trimethoprim/sulfamethoxazole) showed 30 isolates, < 2/38 mg/L and
12 isolates, > 2/38 mg/L. For colistin, 24 isolates, < 0.5 mg/L; 15 isolates, 1
mg/L and 3 isolates, 2 mg/L (100% < 2 mg/L). For tigecycline, 38 isolates, <
1 mg/L and 4 isolates > 2 mg/L.
Conclusions: Among the compounds tested against KPC-17 isolates, colistin
remained the most active drug, followed by amikacin, tigecycline, genta-
micin and co-trimoxazole.
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Purpose: Combined care of central venous catheters has been widely adop-
ted. However, there are many barriers to performing daily assessment of the
condition and need of central venous catheters. In Taiwan, there is a signif-
icant nursing shortage. Establishing an informatics system to remind physi-
cians and nurse to assess catheters and perform combined care of the
catheters can indeed lower the number of days each indwelling catheter
was used and the risk of infection.
Methods: Our hospital established an informatics system to provide a pop-up
reminder for physicians to perform daily assessment of central venous cath-
eters. The system also allow nurses to automatically integrate the assess-
ment into their documentation. This reduced the amount of paperwork
and significantly increased the rate of daily assessment.
Results: After this system was in place, the rate of daily physician assess-
ment improved from 20.3% to 84.7%. The incidence of catheter-associated
infection in ICU decreased by a remarkable 52.2%.
Conclusions: The use of an informatics system can simplify clinical paper-
work, improve staff satisfaction and compliance, and reduce the number
of days of indwelling venous catheters and associated infections.
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Purpose: The regulation mechanism of the AcrAB-TolC efflux pump in Kleb-
siella pneumoniae remains unclear. This study clarified this mechanism and
